drugset / Trial / NCT04910256

Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment

NCT04910256 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study was to evaluate the improvement of limb motor function and nerve function of patients with HTZZ during stroke rehabilitation. A total of 80 subjects will be randomly assigned to Huatuo Zaizao pill group or the control group.

Timeline

Start
2021-05-31
Primary completion
2023-06-20
Completion
2023-09-30

Outcome

Met primary endpoint

paper significant improvements in MAS, NIHSS, FM, and BI scores following 6 and 12 weeks of treatment PMID 40232598 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Huatuo Zaizao Pills Traditional medicine (herbal / TCM) 8 g Oral

Indications